Could a simple shot of gentamicin during C-Sections stop infections?

NCT ID NCT07311395

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study is testing whether giving a single injection of the antibiotic gentamicin into the surgical wound during a planned C-section can reduce the risk of infection afterward. Researchers will compare 100 women who receive this extra local antibiotic plus standard IV antibiotics to those who get standard care alone. Participants are followed for 30 days to check for wound infections and other complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

gentamicin

What this could lead to

If it works, this could offer a simple, low-cost way to prevent wound infections after planned C-sections.

What could go wrong

This is a small pilot study, so results may not be conclusive. The added benefit over standard antibiotics alone is uncertain, and there is a risk of allergic reactions or side effects from gentamicin.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SURGICAL SITE INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Surgical Wound Infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Western Galilee Hospital-Nahariya

    RECRUITING

    Nahariya, Israel

    Contact Phone: •••-•••-•••• Email: •••••@•••••